Report cover image

Global Plasmid Purification Market Size study, by Offering (Products, Services), by Grade (Molecular Grade, Transfection Grade), by Application (Cloning & Protein Expression, Transfection & Gene Editing, Others), by End-use (Pharmaceutical & Biotechnology

Publisher Factview Research
Published Jul 03, 2025
Length 285 Pages
SKU # FAVR20379114

Description

Global Plasmid Purification Market was valued at approximately USD 1.85 billion in 2024, exhibiting a robust CAGR of 12.1% throughout the forecast period from 2024 to 2034. Plasmid purification has emerged as a cornerstone in molecular biology, underpinning a wide array of applications such as gene cloning, genetic engineering, and gene expression studies. This sophisticated process is integral for obtaining high-quality plasmid DNA, which is indispensable for downstream applications including sequencing, transformation, and polymerase chain reactions (PCR). The integrity and purity of plasmid DNA directly influence the success of experiments, especially in transfection assays where gene expression efficiency is paramount. Consequently, the adoption of advanced plasmid purification technologies, which ensure the removal of impurities and deliver high-yield, high-purity plasmid DNA, is on the rise.

The Global Plasmid Purification Market is driven by burgeoning demand for recombinant DNA technology products, coupled with the continuous advancements in purification techniques, serves as a major driving force for market growth. Moreover, the increasing acceptance and implementation of cell and gene therapies in treating chronic diseases further bolster the expansion of this market. However, costs associated with advanced purification methods and regulatory and ethical challenges in gene therapy is going to impede the overall demand for the market during forecast period 2022-2034.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2024, North America, with its leading-edge research facilities, government funding, and commercial demand for molecular cloned products, dominated the market. This region benefits from extensive investments in cell and gene therapy research and development, positioning it as a leader in this space. Futhermore, the Asia Pacific region is poised to experience the fastest growth over the forecast period. Factors such as the rising prevalence of chronic diseases, expanding research activities in genetic engineering, and the growing adoption of gene therapies in this region contribute to its rapid market expansion.

Major market players included in this report are:

Merck KGaA

QIAGEN

Thermo Fisher Scientific, Inc.

Takara Bio

Promega Corporation

Zymo Research

MP Biomedicals

New England Biolabs

MCLAB

Applied Biological Materials Inc.

The detailed segments and sub-segment of the market are explained below:

By Offering
  • Products
  • Services
By Grade
  • Molecular Grade
  • Transfection Grade
By Application
  • Cloning & Protein Expression
  • Transfection & Gene Editing
  • Others
By End-use
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
By Region:

North America
  • U.S.
  • Canada
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
Latin America
  • Brazil
  • Mexico
  • RoLA
Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA
Years considered for the study are as follows:
  • Historical year – 2022
  • Base year – 2024
  • Forecast period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2034.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

285 Pages
Chapter 1. Global Plasmid Purification Market Executive Summary
1.1. Global Plasmid Purification Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Offering
1.3.2. By Grade
1.3.3. By Application
1.3.4. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6 Investment Analysis
1.7 Investment Rationale
1.8 Key Industry Metrics
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Plasmid Purification Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Plasmid Purification Market Dynamics
3.1. Market Drivers
3.1.1. Growing demand for recombinant DNA technology products
3.1.2. Advancements in plasmid purification techniques
3.1.3. Rising acceptance of cell and gene therapy
3.2. Market Challenges
3.2.1. High costs associated with advanced purification methods
3.2.2. Regulatory and ethical challenges in gene therapy
3.3. Market Opportunities
3.3.1. Expansion in Asia Pacific due to rising biotechnology investments
3.3.2. Innovations in purification technologies
3.3.3. Strategic collaborations and partnerships in the biotechnology sector
Chapter 4. Global Plasmid Purification Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Plasmid Purification Market Size & Forecasts by Offering 2024-2034
5.1. Segment Dashboard
5.2. Global Plasmid Purification Market: Offering Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Products
5.2.2. Services
Chapter 6. Global Plasmid Purification Market Size & Forecasts by Grade 2024-2034
6.1. Segment Dashboard
6.2. Global Plasmid Purification Market: Grade Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Molecular Grade
6.2.2. Transfection Grade
Chapter 7. Global Plasmid Purification Market Size & Forecasts by Application 2024-2034
7.1. Segment Dashboard
7.2. Global Plasmid Purification Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Cloning & Protein Expression
7.2.2. Transfection & Gene Editing
7.2.3. Others
Chapter 8. Global Plasmid Purification Market Size & Forecasts by End-use 2024-2034
8.1. Segment Dashboard
8.2. Global Plasmid Purification Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Academic & Research Institutes
8.2.3. Contract Research Organizations
Chapter 9. Global Plasmid Purification Market Size & Forecasts by Region 2024-2034
9.1. North America Plasmid Purification Market
9.1.1. U.S. Plasmid Purification Market
9.1.1.1. Offering breakdown size & forecasts, 2024-2034
9.1.1.2. Grade breakdown size & forecasts, 2024-2034
9.1.1.3. Application breakdown size & forecasts, 2024-2034
9.1.1.4. End-use breakdown size & forecasts, 2024-2034
9.1.2. Canada Plasmid Purification Market
9.1.2.1. Offering breakdown size & forecasts, 2024-2034
9.1.2.2. Grade breakdown size & forecasts, 2024-2034
9.1.2.3. Application breakdown size & forecasts, 2024-2034
9.1.2.4. End-use breakdown size & forecasts, 2024-2034
9.2. Europe Plasmid Purification Market
9.2.1. U.K. Plasmid Purification Market
9.2.2. Germany Plasmid Purification Market
9.2.3. France Plasmid Purification Market
9.2.4. Spain Plasmid Purification Market
9.2.5. Italy Plasmid Purification Market
9.2.6. Rest of Europe Plasmid Purification Market
9.3. Asia-Pacific Plasmid Purification Market
9.3.1. China Plasmid Purification Market
9.3.2. India Plasmid Purification Market
9.3.3. Japan Plasmid Purification Market
9.3.4. Australia Plasmid Purification Market
9.3.5. South Korea Plasmid Purification Market
9.3.6. Rest of Asia Pacific Plasmid Purification Market
9.4. Latin America Plasmid Purification Market
9.4.1. Brazil Plasmid Purification Market
9.4.2. Mexico Plasmid Purification Market
9.4.3. Rest of Latin America Plasmid Purification Market
9.5. Middle East & Africa Plasmid Purification Market
9.5.1. Saudi Arabia Plasmid Purification Market
9.5.2. South Africa Plasmid Purification Market
9.5.3. Rest of Middle East & Africa Plasmid Purification Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Merck KGaA
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. QIAGEN
10.3.3. Thermo Fisher Scientific, Inc.
10.3.4. Takara Bio
10.3.5. Promega Corporation
10.3.6. Zymo Research
10.3.7. MP Biomedicals
10.3.8. New England Biolabs
10.3.9. MCLAB
10.3.10. Applied Biological Materials Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us